These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37385921)

  • 1. Developing kinase inhibitors for malaria: an opportunity or liability?
    Mogwera KSP; Chibale K; Arendse LB
    Trends Parasitol; 2023 Sep; 39(9):720-731. PubMed ID: 37385921
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Arendse LB; Wyllie S; Chibale K; Gilbert IH
    ACS Infect Dis; 2021 Mar; 7(3):518-534. PubMed ID: 33590753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasite and host kinases as targets for antimalarials.
    Ong HW; Adderley J; Tobin AB; Drewry DH; Doerig C
    Expert Opin Ther Targets; 2023 Feb; 27(2):151-169. PubMed ID: 36942408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial efficacy of MMV390048, an inhibitor of
    Paquet T; Le Manach C; Cabrera DG; Younis Y; Henrich PP; Abraham TS; Lee MCS; Basak R; Ghidelli-Disse S; Lafuente-Monasterio MJ; Bantscheff M; Ruecker A; Blagborough AM; Zakutansky SE; Zeeman AM; White KL; Shackleford DM; Mannila J; Morizzi J; Scheurer C; Angulo-Barturen I; Martínez MS; Ferrer S; Sanz LM; Gamo FJ; Reader J; Botha M; Dechering KJ; Sauerwein RW; Tungtaeng A; Vanachayangkul P; Lim CS; Burrows J; Witty MJ; Marsh KC; Bodenreider C; Rochford R; Solapure SM; Jiménez-Díaz MB; Wittlin S; Charman SA; Donini C; Campo B; Birkholtz LM; Hanson KK; Drewes G; Kocken CHM; Delves MJ; Leroy D; Fidock DA; Waterson D; Street LJ; Chibale K
    Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting malaria protein kinases.
    Cassiano GC; Tavella TA; Nascimento MN; Rodrigues DA; Cravo PVL; Andrade CH; Costa FTM
    Adv Protein Chem Struct Biol; 2021; 124():225-274. PubMed ID: 33632466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048.
    McCarthy JS; Donini C; Chalon S; Woodford J; Marquart L; Collins KA; Rozenberg FD; Fidock DA; Cherkaoui-Rbati MH; Gobeau N; Möhrle JJ
    Clin Infect Dis; 2020 Dec; 71(10):e657-e664. PubMed ID: 32239164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical interrogation of the malaria kinome.
    Derbyshire ER; Zuzarte-Luís V; Magalhães AD; Kato N; Sanschagrin PC; Wang J; Zhou W; Miduturu CV; Mazitschek R; Sliz P; Mota MM; Gray NS; Clardy J
    Chembiochem; 2014 Sep; 15(13):1920-30. PubMed ID: 25111632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria: targeting parasite and host cell kinomes.
    Doerig C; Abdi A; Bland N; Eschenlauer S; Dorin-Semblat D; Fennell C; Halbert J; Holland Z; Nivez MP; Semblat JP; Sicard A; Reininger L
    Biochim Biophys Acta; 2010 Mar; 1804(3):604-12. PubMed ID: 19840874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition.
    Demarta-Gatsi C; Donini C; Duffy J; Sadler C; Stewart J; Barber JA; Tornesi B
    Birth Defects Res; 2022 Jun; 114(10):487-498. PubMed ID: 35416431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges.
    Doerig C; Grevelding CG
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1637-43. PubMed ID: 25770683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for Inhibitor Potency and Selectivity of
    Fienberg S; Eyermann CJ; Arendse LB; Basarab GS; McPhail JA; Burke JE; Chibale K
    ACS Infect Dis; 2020 Nov; 6(11):3048-3063. PubMed ID: 32966036
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting protein kinases in the malaria parasite: update of an antimalarial drug target.
    Zhang VM; Chavchich M; Waters NC
    Curr Top Med Chem; 2012; 12(5):456-72. PubMed ID: 22242850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria.
    Mohammed R; Asres MS; Gudina EK; Adissu W; Johnstone H; Marrast AC; Donini C; Duparc S; Yilma D
    Am J Trop Med Hyg; 2023 Jan; 108(1):81-84. PubMed ID: 36509063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KinomeMETA: meta-learning enhanced kinome-wide polypharmacology profiling.
    Ren Q; Qu N; Sun J; Zhou J; Liu J; Ni L; Tong X; Zhang Z; Kong X; Wen Y; Wang Y; Wang D; Luo X; Zhang S; Zheng M; Li X
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38113075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets.
    Sumi NJ; Ctortecka C; Hu Q; Bryant AT; Fang B; Remsing Rix LL; Ayaz M; Kinose F; Welsh EA; Eschrich SA; Lawrence HR; Koomen JM; Haura EB; Rix U
    Cell Chem Biol; 2019 Sep; 26(9):1240-1252.e11. PubMed ID: 31257184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38.
    Armstrong JF; Campo B; Alexander SPH; Arendse LB; Cheng X; Davenport AP; Faccenda E; Fidock DA; Godinez-Macias KP; Harding SD; Kato N; Lee MCS; Luth MR; Mazitschek R; Mittal N; Niles JC; Okombo J; Ottilie S; Pasaje CFA; Probst AS; Rawat M; Rocamora F; Sakata-Kato T; Southan C; Spedding M; Tye MA; Yang T; Zhao N; Davies JA
    Br J Pharmacol; 2023 Aug; 180(15):1899-1929. PubMed ID: 37197802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer.
    Nandi S; Chauhan B; Tarannum H; Khede MK
    Curr Top Med Chem; 2023; 23(5):403-414. PubMed ID: 36694313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Activity-Based Protein Profiling in Malaria Drug Discovery.
    Carvalho LAR; Bernardes GJL
    ChemMedChem; 2022 Jul; 17(14):e202200174. PubMed ID: 35506504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.